Non-Hodgkin lymphoma is a group of blood cancers affecting the lymphatic system, presenting with painless swollen lymph nodes, fatigue, night sweats, and weight loss. It is more common than Hodgkin lymphoma.
Bortezomib is a proteasome inhibitor used in the treatment of hematological malignancies including multiple myeloma.
Lenalidomide is a proteasome inhibitor used in the treatment of hematological malignancies including multiple myeloma.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: